Dong-A Pharm to conduct additional study for Zydena

Published: 2006-06-27 06:57:00

Updated: 2006-06-27 06:57:00

Dong-A Pharm is set to additionally conduct its local clinical study to evaluate the safety and efficacy of Zydena, the first-domestically-made medication for erectile dysfunction, in patients with hypertension and diabetes.

The clinical study for hypertensive patients will be conducted at eig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK